Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death among women worldwide. The U.S. Centers for Disease Control and Prevention provides an overview of Basic Information about Breast Cancer.
Below is an updated directory of published research focusing on overall trends in breast cancer epidemiology, prevalence, testing, diagnosis, risk assessment, treatment strategies, emotional support, and patient consultations with a special emphasis on literature referencing women exposed to DES–diethylstilbestrol (mothers and offspring). This guide continues to evolve over time and areas of focus in 2025.
>>> DES Research Note: Historically, research on DES-exposed mothers as well as their daughters has identified an increased risk of developing breast cancer (cite Hilakivi-Clarke, 2014). The latest available guide to Diethylstilbestrol (DES) Exposure and Cancer (2022) from the National Cancer Institute recognizes that DES daughters after age 40 have approximately twice the risk of developing breast cancer as unexposed women. References with focus on or inclusion of DES effects are marked with (*).
Topics Included in Research Covered in this Guide:
Health and Medical Issues
* Breast cancer risk factors
* Breast cancer epidemiology
* Screening, detection, and diagnosis
* Varieties of symptoms of breast cancer
* Aging and increases in breast cancer risk and mortality
* Stages of breast cancer detection and diagnosis
* Time from cancer detection to treatment, especially surgery
* Determination of treatment therapies and options
* Survival and mortality rates and various related factors
* Mammographic screening options
* Types of breast cancer, classifications, and various related factors
* Triple-negative breast cancer
* Treatment options and patient care
* Surgery approaches, including breast concerving options
* Chemotherapy strategies and effects
Psychological/Emotional Effects and Support
* Identification of supportive care options
* Managing emotional effects of diagnosis and treatment, especially anxiety and depression
* Psychological interventions at early stages of diagnosis and ongoing
* Strengthening self-compassion and post-traumatic growth
* Importance of social support networks, in-person and online
* Cognitive-behavioral therapy for patients
* Internet-delivered psychotherapy where possible
October 2025 Update–Comprehensive Review of Published Research**
2024-25
** Note: A 7-page summary guide DES (Diethylstilbestrol) Exposure and Breast Cancer Risk updated in June 2024 is available upon request.
- * {NEW} Cancer risk after in utero exposure to diethylstilbestrol (2025), by Naomi B. Boekel, et al., published in the European Journal of Epidemiology
- (**) {NEW} Breast Cancer: Pathogenesis and Treatment (2025), by Xin Xiong, et al., published in the journal Signal Transduction and Targeted Therapy
- {NEW} Cardiovascular Disease and Breast Cancer Stage at Diagnosis (2025), by Ivan Angelov, et al., published in JAMA Network Open (full-text)
- (*) {NEW} Estrogens and Breast Cancer (2025), by J. Kim & P.N. Munster, published in Annals of Oncology
- {NEW} Global patterns and trends in breast cancer incidence and mortality across 185 countries (2025), by Joanne Kim, et al., published in Nature Medicine
- {NEW} Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021 (2025), by Tianye Li, et al., published in Journal of Hematology & Oncology
- (*) {NEW} Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data (2025), by Dan-Dan Tang, et al., published in the journal The Breast
- (*) {NEW} Nutrition in Breast Cancer (2025), by Emine Merve Ekici, published in the textbook Managing Side Effects of Breast Cancer Treatment
- {NEW} Inequality in Breast Cancer: Global Statistics from 2022 to 2050 (2025), by Ling Lao, et al., published in The Breast
- (*) {NEW} Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK – Breast Cancer Prevention Conference (2024), by Britta Stordal, et al., published in the journal Cancer Medicine (full-text)
- (*) {NEW} Impact of Cumulative Exposure to Circulating Ovarian Sex Hormones on Increasing the Risk of Hormone Receptor-Positive Breast Cancer (2024), by Swati Sucharita Mohanty, et al., published in the Journal of BioX Research (full-text)
- (*) {NEW} Management of Women at High Risk for Breast Cancer (2024), by Lashika Yogendran, et al., published in the Journal of the American Board of Family Medicine (abstract)
- (*) {NEW} Factors Impacting Quality of Life for Breast Cancer Survivors (2024), by Stephanie C. Davis, et al., published in the journal The Nurse Practitioner (full-text)
- {NEW} Cancer Stat Facts: Female Breast Cancer (2024 Update), from the National Cancer Institute (full-text)
- {NEW} Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study (2024), by Linda Titus, et al., published in the journal Cancers (full-text)
- (*) {NEW} Beyond Milk and Nurture: Breastfeeding’s Powerful Impact on Breast Cancer (2024), by Muhammad Mustafa, published in the journal
Geburtshilfe und Frauenheilkunde - {NEW} Impact of Cumulative Exposure to Circulating Ovarian Sex Hormones on Increasing the Risk of Hormone Receptor-Positive Breast Cancer (2024), by SWATI SUCHARITA MOHANTY, et al., published in the Journal of Bio-X Research (full-text)
- {NEW} Breast Cancer: A Review of Risk Factors and Diagnosis (2024), by Emmanuel Ifeanyi Obeagu, published in the journal Medicine (full-text)
- {NEW} Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence (2024), by Mariia Ivanova, et al., published in the journal Cancers (full-text)
- {NEW} Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force (2024), by Jillian T. Henderson, et al., published in The Journal of the American Medical Association
- {NEW} Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement (2024), published in The Journal of the American Medical Association
- {NEW} Editorial: The Pros and Cons of Breast Cancer Screening in Older Women (2024), by Andy Evans, published in the Annals of Breast Surgery (full-text)
- {NEW} Causes and Risk Factors of Breast Cancer, What Do We Know for Sure? An Evidence Synthesis of Systematic Reviews and Meta-Analyses (2024), by Borghild Løyland, et al., published in the journal Cancers (full-text)
- {NEW} Physical health-related quality of life trajectories over two years following breast cancer diagnosis in older women: a secondary analysis (2024), by Shan S. Wong, et al., published in the journal Supportive Care in Cancer (full-text)
- {NEW} Breast Cancer Risk Factors among Women with Solid Breast Lesions (2024), by Ivana Eremici, et al., published in the journal Clinics and Practice (full-text)
- {NEW} Analysis of Breast Cancer Mortality in the US—1975 to 2019 (2024), by Jennifer L. Caswell-Jin, MD, published in the Journal of the American Medical Association (JAMA) Network
- {NEW} Early Breast Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-up (2024), by S. Loibl, et al., published in the journal Annals of Oncology (full-text)
- * {NEW} Does Laterality in Breast Cancer still have the Importance to be Studied? A Meta-analysis of Patients with Breast Cancer (2024), by Zheng, Xiao, et al., published in Current Medicinal Chemistry
- {NEW} Factors Influencing Older Women’s Decision-making Related to Treatment of Operable Breast Cancer: A Qualitative Systematic Review (2024), by Francesca Ligori Malcolm, et al., published in the journal Psycho-Oncology (abstract)
- {NEW} Quality of Life Outcomes Associated With Optimization of Treatment by Omitting Radiotherapy in Early Breast Cancer (2024), by Lesley Stafford, et al., published in the journal Clinical Breast Cancer (abstract)
- {NEW} Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer (2024), by Andreas D. Lauritzen, et al., published in the journal Radiology (full-text)
- (*) {NEW} Estrogen-induced Reactive Oxygen Species, through Epigenetic Reprogramming, Causes Increased Growth in Breast Cancer Cells (2024), by Priti Roy, et al., published in the journal Molecular and Cellular Endocrinology (full-text)
- (*) {NEW} The Integration of Multidisciplinary Approaches Revealed PTGES3 as a Novel Drug Target for Breast Cancer Treatment (2024), by Qinan Han, et al., published in the Journal of Translational Medicine (full-text)
- {NEW} Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study (2024), by Dankee Yang, et al., published in the journal Cancer Research & Treatment
- {NEW} Distress and Psycho-Oncological Support for Patients With Advanced Breast Cancer (2024), by Luzia Travado & Leonor Bastos, published in Seminars in Oncology Nursing
2023 - (*) {NEW} Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches (2023), by Nivida Shete, et al., published in the journal Cancers (full-text)
- {NEW} Advancements in Clinical Aspects of Targeted Therapy and Immunotherapy in Breast Cancer (2023), by Feng Ye, et al., published in the journal Molecular Cancer (full-text)
- (*) {NEW} An Update on Breast Cancer Chemotherapy-Associated Toxicity and their Management Approaches (2023), by Urvashi Langeh, et al., published in the journal Health Sciences Review (full-text)
- {NEW} Immunotherapy in Breast Cancer: An Overview of Current Strategies and Perspectives (2023), by Veronique Debien, et al., published in the journal NPJ Breast Cancer (full-text)
- {NEW} Epidemiology Trends and Progress in Breast Cancer Survival: Earlier Diagnosis, New Therapeutics (2023), by Ottavia Omato, published in Current Opinion in Oncology (full-text)
- {NEW} Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer (2023), by Ian H. Kunkler, et al., published in the New England Journal of Medicine (full-text)
- {NEW} Breast Cancer: Updated and Deep Insights (2023), by Kimberly Morton Cuthrell and Nikolaos Tzenios, published in the International Research Journal of Oncology (full-text)
- {NEW} Metastatic Breast Cancer: Review of Emerging Nanotherapeutics (2023), by Ranga Dissanayake, et al., published in the journal Cancers (abstract)
- {NEW} What works in peer support for breast cancer survivors: A qualitative systematic review and meta-ethnography (2023), by Derek Clougher, et al., published in Applied Psychology: Health and Well-Being
- {NEW} A cross-sectional comparative study of self-compassion, body perception, and post-traumatic growth in women diagnosed with breast cancer versus those without a cancer diagnosis (2023), by Servan Kaplan, et al., published in the journal Cancer Research, Statistics, & Treatment
- {NEW} Targeting Breast Cancer: The Familiar, the Emerging, and the Uncharted Territories (2023), by Hamidreza Montazeri Aliabadi, et al., published in the journal Biomolecules (full-text)
- {NEW} Early-Stage Breast Cancer Detection in Breast Milk (2023), by Cristina Saura, et al., published in the journal Cancer Discovery (full-text)
- {NEW} Reexamining Time From Breast Cancer Diagnosis to Primary Breast Surgery (2023), by Alyssa A. Wiener, et al., published in JAMA Surgery (full-text)
- {NEW} Modifiable risk factors in women at high risk of breast cancer: a systematic review (2023), by Sarah Y. Cohen, et al., published in the journal Breast Cancer Research (full-text)
- {NEW} Breast Cancer Patients’ Needs and Perspectives on a One-on-one Peer Support Program: Quantitative and Qualitative Analyses (2023), by Britt AM Jansen, et al., published in the journal Supportive Care in Cancer (full-text)
- {NEW} Spiritual and Emotional Experience With a Diagnosis of Breast Cancer: A Scoping Review (2023), by Diva Cristina Leao, et al., published in the journal Cancer Nursing (full-text)
- * {NEW} Clinical Evaluation of Patients Suffering from Breast Cancer and Determination of Evolving Treatment Therapies and Better Strategies Related to Breast Cancer (2023), by Iqra Saleem, et al., published in the International Journal of Natural Medicine & Health Sciences (abstract)
- {NEW} The Role of Social Networks in the Self-management Support for Young Women Recently Diagnosed with Breast Cancer (2023), by Ivaylo Vassilev, et al., published in the journal PLOS One
- {NEW} Psychological Interventions for Women with Non‐metastatic Breast Cancer (2023), by Ghufran A Jassim, et al., published in the Cochran Database of Systematic Reviews
- * {NEW} Estrogens and the Risk of Breast Cancer: A Narrative Review of Literature (2023), by Khayry Al-Shami, et al., published in the journal Heliyon (full-text)
- {NEW} Exploring the Unmet Supportive Care Needs of Breast Cancer Survivors Experiencing Psychological Distress: Qualitative Study (2023), by Figen Sengun Inan, et al., published in the journal Seminars in Oncology Nursing (full-text)
- {NEW} Biologic Profile to Predict Overall Survival in Non-metastatic Breast Cancer: A Latent Class Analysis on Aging Biomarkers (2023), by Claire Falandry, et al., published in the Journal of Clinical Oncology (full-text)
- {NEW} Perceptions of Breast Cancer Risks Among Women Receiving Mammograph Screening (2023), by Laura B. Beidler, et al., published in JAMA: Oncology (full-text)
- {NEW} Breast Cancer Survivorship Experiences among Black Women (2023), by Naomi Y. Ko, et al., published in the journal Cancer (full-text)
- {NEW} Targeting Breast Cancer: An Overlook on Current Strategies (2023), by Domenico Iacopetta, et al., published in the International Journal of Molecular Sciences (full-text)
- (*) Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence (2023), by Nahlah Makki Almansour, published in the journal Frontiers in Molecular Bioscience (full-text)
- (*) Identification and Strategies for Triple-negative Breast Cancer Subtypes (2023), by Rokhim Suryadi, et al., published in the journal Science Midwifery (abstract)
- (*) Etiology of Breast Cancer (2023), by Rajveer Singh & Nitesh Kumar Sain, published in the Journal of Pharmaceutical Negative Results (abstract)
- Cancer Statistics, 2023 (2023), by Rebecca L. Siegel, et. al, published in the journal CA: A Cancer Journal for Clinicians (full-text)
- {NEW} Risks of Second Non-breast Primaries Following Breast Cancer in Women: A Systematic Review and Meta-analysis (2023), by Isaac Allen, et al., published in the journal Breast Cancer Research
- {NEW} Antibody–drug Conjugates: The Evolving Field of Targeted Chemotherapy for Breast Cancer Treatment (2023), by Guilherme Nader-Marta, et al., published in the journal Therapeutic Advances in Medical Oncology (full-text)
- A Model for Predicting both Breast Cancer Risk and non-breast Cancer Death Among Women >55 Years Old (2023), by Mara A. Schonberg, et. al, published in the journal Breast Cancer Risk (full-text)
- Breast Cancer Brain Metastasis: From Etiology to State-of-the Art Modeling (2023), by Mohammad Farahani, et al., published in the Journal of Biological Engineering (full-text)
- Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? (2023), by Silvia Riondino, et. al, published in the journal Current Oncology (full-text)
- Perceptions of Breast Cancer Risks among Women Receiving Mammographic Screening (2023), by Laura B. Beidler, et al., published in the journal JAMA Network Open (full-text)
- The Relationship Between Diet Quality Indices and Odds of Breast Cancer in Women: A Case-Control Study (2023), by Mohammad Hassan Sohouli, et al., published in the journal BMC Women’s Health(f-t)
- {NEW} Mammography in Combination with Breast Ultrasonography versus Mammography for Breast Cancer Screening in Women at Average Risk (2023), by Gerald Gartlehner, et al., published in the Cochrane Database Systematic Review
- {NEW} Extensive Review on Breast Cancer: Its Etiology, Progression, Prognostic Markers, and Treatment (2023), by Harshini Swaminathan, et al., published in the journal Medical Oncology (abstract)
- {NEW} Familial Aggregation of Early-onset Cancers in Early-onset Breast Cancer Families (2023), by Jasmiina N.J. Rantala, et al., published in the International Journal of Cancer (full-text)
- Breast Cancer Screening in High-risk Women During Pregnancy and Lactation (2023), by Leah H. Portnow, et al., published in the Journal of Breast Imaging (full-text)
- (*) Management of the Triple Negative Locally Advanced Breast Cancer (2023), by Amir Iqbal Memon, et al., published chapter from the textbook Breast Cancer Updates (full-text)
- {NEW} Barriers to Breast Cancer-Screening Adherence in Vulnerable Populations (2023), by Laura Ponce-Chazarri, et al., published in the journal Cancers (full-text)
- {NEW} Challenges and Changes of the Breast Cancer Screening Paradigm (2023), by Didem Comert, et. al., published in the Journal of Magnetic Resonance Imaging (full text)
- {NEW} Research: Breast Cancer Mortality in 500 000 Women with Early Invasive Breast Cancer Diagnosed in England, 1993-2015: Population Based Observational Cohort Study (2023), by Carolyn Taylor, published in the British Medical Journal (the BMJ) (full-text)
- (*) {NEW} Breast Cancer: Updated and Deep Insights (2023), by Kimberly Morton Cutrell & Nikolas Tzenios, published in the International Research Journal of Oncology (abstract only)
- {NEW} A Comprehensive Review on Multifaceted Mechanisms Involved in the Development of Breast Cancer Following Adverse Childhood Experiences (ACEs) (2023), by Olimpia Pino, published in the International Journal of Environmental Research and Public Health (full-text)
- {NEW} Proactive Breast Cancer Risk Assessment in Primary Care: A Review Based on the Principles of Screening (2023), by Juliet A. Usher-Smith, et al., published in the British Journal of Cancer (full-text)
- (*) {NEW} Breast Cancer: Epidemiology, Types, Diagnosis, and Treatment (2023), by Madhumita Roy, et al., published in the textbook Genetics and Epigenetics of Breast Cancer
- {NEW} Changes in the Mammary Gland during Aging and its Links with Breast Diseases (2023), by Junquian Ling, et al., published in the journal Acta Biochim Biophys Sin (Shanghai) (full-text)
- {NEW} Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study (2023), by Ji Jingran, et al., published in the Journal of Clinical Oncology (full-text)
- An Emerging Generation of Endocrine Therapies in Breast Cancer: A Clinical Perspective (2023), by Rima Patel, et al., published in the journal NPJ Breast Cancer (full-text)
- Immunotherapy in Breast Cancer: An Overview of Current Strategies and Perspectives (2023), by Veronique Debien, et al., published in the journal NPJ Breast Cancer (full-text)
- Estrogen Therapy After Breast Cancer Diagnosis and Breast Cancer Mortality Risk (2023), by Maria Sund, et al., published in the journal Breast Cancer Research and Treatment
- Look How Far We Have Come: BREAST Cancer Detection Education on the International Stage (2023), by Phuong Dung Trieu et al., published in the journal Frontiers in Oncology
- Reexamining Time from Breast Cancer Diagnosis to Primary Breast Surgery (2023), by Alyssa A. Wiener, et al., published in the journal JAMA Surgery (abstract only)
- Psychological Interventions for Women with Non-Metastatic Breast Cancer (2023), by Ghufran A. Jassim, et al., published in the Cochrane Database of Systematic Reviews (excerpts)
- Computer-aided Breast Cancer and Classification in Mammography: A Comprehensive Review (2023), by Kosmia Liizidou, et al., published in the journal Computers in Biology and Medicine (full-text)
- Hereditary Breast Cancer: Syndromes, Tumour Pathology and Molecular Testing (2023), by A. Sokolova, et al., published in the journal Histopathology
- (*) Parental Occupational Exposure to Chemicals and Risk of Breast Cancer in Female Offspring (2023), by Julie Elbaek Pedersen & Johnni Hansen, published in the journal Environmental Research
- Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer (2023), by Ian H. Kunkler, et. al, published in the New England Journal of Medicine (abstract only)
- Identification and Strategies for Triple-negative Breast Cancer Subtypes (2023), by Rokhim Suryadi, et. al, published in the journal Science Midwifery (full-text)
- The Causal Effect of Reproductive Factors on Breast Cancer: A Two-Sample Mendelian Randomization Study (2023), by Lijun Jia, et. al, published in Journal of Clinical Medicine
- Trends in Breast Cancer Mortality by Race/Ethnicity, Age, and U.S. Census Region, United States, 1999-2020 (2023), by Taylor D. Ellington, et. al, published in the journal Cancer (abstract only)
- Racial Disparities in Breast Cancer Treatment Patterns and Treatment-Related Adverse Events (2023), by Nickolas Stabellini, et. al, published in the journal Scientific Reports
- Back to the Beginning: The Role of Ovarian Suppression in Management of Hormone Sensitive Breast Cancer in Premenopausal Women (2023), by Roisin M. Connolly, et al., published in the Journal of Clinical Oncology (full-text)
- Internet-delivered Cognitive Behavioural Therapy for Depression and Anxiety in Breast Cancer Survivors: Results from a Randomized Controlled Trial (2023), by Selin Akkol-Solakoglu & David Hevey, published in the journal Psycho-Oncology (full-text)
- Exploring Types of Conversational Agents for Resolving Cancer Patients’ Questions and Concerns: Analysis of 100 Telephone Consultations on Breast Cancer (2023), by Masayo Hayakawa, et al., published in the journal Patient Education and Counseling (full-text)
- Low Rates of Medical Oncology Consultation for Older Women (>70 Years) with Newly Diagnosed, Non-Metastatic Breast Cancer: A Population-Based Study (2023), by Gary Ko, et al., published in the journal Annals of Surgical Oncology (full-text)
- Emergency Department Visits and Hospitalizations in Older Women Treated for Early Stage Breast Cancer (2023), by Dillon C. Cockrell, et. al, published in the Journal of Geriatric Oncology (abstract only)
2022 - Triple Negative Breast Cancer: Pitfalls and Progress (2022), by Paola Zagami & Lisa Anne Carey, published in the journal npj Breast Cancer (full-text)
- {NEW} Risk of Second Primary Cancer among Women in the Kaiser Permanente Breast Cancer Survivors Cohort (2022), by Cody Ramin, et al., published in the journal Breast Cancer Research
- (*) Breast Cancer Research, Current Therapeutic Pipeline Provide Significant Advancements in Diagnosis, Treatment (2022), by Rachel K. Anderson, published in Pharmacy Times Oncology Edition
- Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population (2022) , by Karla Kerlikowske, et al, published in the Journal of the National Cancer Institute
- Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine (2022), by Françoise Derouane, et al., published in the journal Cancers (full-text)
- {NEW} Global Challenges in Breast Cancer Detection and Treatment (2022), by Carlos H. Barrios, published in a special issue of the journal The Breast (full-text)
- {NEW} Neoadjuvant Approach in Patients with Early Breast Cancer: Patient Assessment, Staging, and Planning (2022), by Isabel T. Rubio & Carolina Sobrido, published in a special issue of the journal The Breast (full-text)
- (*) Epigenetic Inheritance: Intergenerational Effects of Pesticides and Other Endocrine Disruptors on Cancer Development (2022), by Heloiza Diniz Nicolella and Sonia de Assis, published in the International Journal of Molecular Sciences (abstract)
- {NEW} Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update (2022), by Fabrice Andre, et al., published in the Journal of Clinical Oncology (full-text)
- {NEW} Effect of Physical Exercise on Cognitive Function after Chemotherapy in Patients with Breast Cancer: A Randomized Controlled Trial (PAM Study) (2022), by E. W. Koevoets, et al. published in the journal Breast Cancer Research (full-text)
- {NEW} Residual Cancer Burden after Neoadjuvant Chemotherapy and Long-term Survival Outcomes in Breast Cancer: A Multicentre Pooled Analysis of 5161 Patients (2022), by Christina Yau, et al., published in the journal The Lancet–Oncology (full-text)
- Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy (2022), by Antonio Di Meglio, et al., published in the Journal of Clinical Oncology (full-text)
- Dietary Fat Intake: Associations with Dietary Patterns and Postmenopausal Breast Cancer—A Case-Control Study (2022), by Beata Stasiewicz, et al., published in the the journal Cancers (full-text)
- Do Current Family History-based Genetic Testing Guidelines Contribute to Breast Cancer Health Inequities? (2022), by Samantha H. Jakuboski, et al, published in the journal NPJ Breast Cancer
- Breast Cancer: An Up-to-date Review and Future Perspectives (2022), by Ruoxi Hong & Binghe Xu, published in the journal Cancer Communications (full-text)
- New and Emerging Targeted Therapies for Advanced Breast Cancer (2022), by Kristie H. Lau, et al., published in the International Journal of Molecular Sciences (full-text)
- Benefits and Harms of Annual, Biennial, or Triennial Breast Cancer Mammography Screening for Women at Average Risk of Breast Cancer: A Systematic Review for the European Commission Initiative on Breast Cancer (ECIBC) (2022), by Carlos Canelo-Aybar, et. al, published in the British Journal of Cancer (full-text)
- Evolution of Medical Approaches and Prominent Therapies in Breast Cancer (2022), by Suzann Duan & Iain L.O. Buxton, published in the journal Cancers (full-text)
- Breast Cancer Statistics, 2022 (2022), by Angela N. Giaquinto, et. al, published in CA: A Cancer Journal for Clinicians (full-text)
- Depression in Breast Cancer Patients: Immunopathogenesis and Immunotherapy (2022), by Sheng Wu, et al., published in the journal Cancer Letters (abstract)
- Breast Cancer–Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature) (2022), by Beata Smolarz, et al., published in the journal Cancers (full-text)
- Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040 (2022), by Melina Arnold, et. al, published in the journal The Breast (full-text)
- Understanding Breast Cancer as a Global Health Concern (2022), by Louise Wilkinson & Toral Gathani, published in The British Journal of Radiology (full-text)
- Global Challenges in Breast Cancer Detection and Treatment (2022), by Carlos H. Barrios, published in the journal The Breast (full-text)
- Endocrine Disrupting Chemicals and Breast Cancer: A Systematic Review of Epidemiological Studies (2022), by Murphy Lam Yim Wan, et. al, published in the journal Critical Reviews in Food Science and Nutrition (full-text)
- Breast Cancer in the Era of Integrating “Omics” Approaches (2022), by Claudia Rossi, et al., published in the journal Oncogenesis (full-text)
2021 - (*) Diethylstilbestrol (DES) Exposure and Cancer (2021), published summary from the National Cancer Institute (full-text with links)–see section on Breast Cancer for comparative focus on level of risk
- (*) Are the Effects of DES Over? A Tragic Lesson from the Past (2021), by Pilar Zamora-Leon, published in the International Journal of Environmental Research and Public Health
- (*) Evidence of Intergenerational Transmission of Diethylstilbestrol Health Effects: Hindsight and Insight (2021), by Linda Titus, published in the journal Biology of Reproduction (full-text)
- (*) The Heritable Legacy of Diethylstilbestrol: A Bellwether for Endocrine Disruption in Humans (2021), by Suzanne Robotti, published in the journal Biology of Reproduction (full-text)
- (*) Breast Cancer–Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies–An Updated Review (2021), by Sergiusz Lukasiewicz, et. al, published in the journal Cancers (full-text) (overall study; not limited to DES)
- Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed with Breast Cancer or Ovarian Cancer (2021), by Allison W. Kurian, et al, published in the Journal of Clinical Oncology (full-text)
- (*) Cancer Progress and Priorities: Breast Cancer (2021), by Serena C. Houghton & Susan E. Hankinson, published in the journal Cancer Epidemiology, Biomarkers & Prevention (f-t)
- Current State of Breast Cancer Diagnosis, Treatment, and Theranostics (2021), by Arya Bushan, et al., published in the journal Pharmaceutics (full-text)
- {NEW} Experiences of Self-Criticism and Self-Compassion in People Diagnosed With Cancer: A Multimethod Qualitative Study (2021), by Judith Austin, et al., published in the journal Frontiers in Psychology
- The Hypothesis of Fetal Origin of Breast Cancer: An Update (2021), by Tongzhang Zheng, et. al, published in the journal Women’s Health Research (full-text)
- Exposure to Endocrine Disruptors and Risk of Breast Cancer: A Systematic Review (2021), by Priscilla Roberta Silva Rocha, et al., published in the journal Critical Reviews in Oncology/Hematology (full-text)
2020 - (*) Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer (2020), by Louisane Eve, et. al, published in the International Journal of Molecular Sciences (full-text)
- (*) Endocrine Disruptors from the Environment Affecting Breast Cancer (Review) (2020), by Gloria M. Calaf, et al., published in the journal Oncology Letters (full-text)
- Breast Cancer in Women: A Descriptive Analysis of the National Cancer Database (2020), by Andrea Sisti, et. al, published in the journal Acta Biomedica (full-text)
- (*) Heightened Susceptibility: A Review of How Pregnancy and Chemical Exposures Influence Maternal Health (2020), by Julia Varshavsky, et al., published in the journal Reproductive Toxicology
- Applying the New Guidelines of HER2 Testing in Breast Cancer (2020), by Huina Zhang, et al, published in the journal Current Oncology Reports (abstract only)
- Beyond Chemotherapies: Recent Strategies in Breast Cancer Treatment (2020), by Arthur Foulon, et al., published in the journal Cancers (full-text)
- Endocrine-Disrupting Chemicals and Their Effects during Female Puberty: A Review of Current Evidence (2020), by Laura Lucaccioni, et al., published in the International Journal of Molecular Sciences (full-text)
- Germline Genetic Testing in Breast Cancer: Rationale for the Testing of all Women Diagnosed by the Age of 60 years and for Risk-Based Testing of Those Older than 60 Years (2020), by Neelam V. Desai, et al, published in the journal Cancer (full-text)
- Prevalence and Intensity of Persistent Post-Surgical Pain Following Breast Cancer Surgery: A Systematic Review and meta-analysis of Observational Studies (2020), by Li Wang, et. al, published in the British Journal of Anaesthesia (abstract only)
- Treatment Strategies and Survival Outcomes in Breast Cancer (2020), by Kwok-Leung Cheung, published in the journal Cancers (full-text)
- Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update (2020), published in the journal Archives of Pathology & Laboratory Medicine (full-text)
2010-2019 - Systematic Treatment and Radiotherapy, Breast Cancer Subtypes, and Survival after Long-term Clinical Follow-up (2019), by Sherry X. Yang & Eric C. Polley, published in the journal Breast Cancer Research and Treatment (full-text)
- Breast Cancer Treatment and its Effects on Aging (2019), by Leslie Chang, et al., published in the Journal of Geriatric Oncology (full-text)
- (*) Prenatal Diethylstilbestrol Exposure and Cancer Risk in Women (2019), by Rebecca Troisi, et. al, published in the journal Environmental and Molecular Mutagenesis (abstract)
- Recent Advances in Understanding Breast Cancer and Emerging Therapies with a Focus on Luminal and Triple-Negative Cancer (2019), by Georges El Hachem, et al., published in the journal F1000Research (full-text)
- Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients (2019), by Allison W. Kurian, et al, published in the Journal of Clinical Oncology
- Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? (2019), by Peter D. Beitsch, et al., published in the Journal of Clinical Oncology
- Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons (2019), by Eric R. Manahan, et al., published in the journal Annals of Surgical Oncology (full-text)
- Increasing Role of Oncoplastic Surgery for Breast Cancer (2019), by Cary S. Kaufman, published in the journal Current Oncology Reports (full-text)
- (*) Prenatal Diethylstilbestrol Exposure and Mammographic Density (2018), by William C. Strohsnitter, et. al, published in the International Journal of Cancer (full-text)
- (*) Estrogen Metabolism in Postmenopausal Women Exposed In Utero to Diethylstilbestrol (2018), by Rebecca Troisi, et al., published in the journal Cancer Epidemiology, Biomarkers & Prevention (full-text)
- Perceptions of Support Groups Among Older Breast Cancer Survivors“I’ve Heard of Them, but I’ve Never Felt the Need to Go” (2018), by Emily K. Green, et al., published in the journal Cancer Nursing
- Environmental Chemicals and Breast Cancer: An Updated Review of Epidemiological Literature Informed by Biological Mechanisms (2018), by KM Rogers, et. al, published in the journal Environmental Research (full-text)
- State of the Evidence 2017: An Update on the Connection Between Breast Cancer and the Environment (2017), by Janet M Gray, et. al, published in the journal Environmental Health
- (*) Review: Current Perspective of Diethylstilbestrol (DES) Exposure in Mothers and Offspring (2017), by Taher Al Jishi & Consaloto Sergi, published in the journal Reproductive Toxicology
- (*) Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk (2017), by Genevieve Victoria Dall & Kara Louise Britt, published in the journal Frontiers in Oncology (full-text)
- Breast Cancers are Rare Diseases–and Must be Treated as Such (2017), by John M. S. Bartlett & Wendy Parelukar, published in the journal NPJ Breast Cancer (full-text)
- (*) The Diethylstilbestrol Legacy: A Powerful Case Against Intervention in Uncomplicated Pregnancy (2016), by Rebecca Troisi, et al., published in the journal Pediatrics (full-text)
- (*) Cancer Risk in Women Exposed to Diethylstilbestrol in Utero (2015), by Michel Tournaire, et. al, published in the journal Therapie (abstract only)
- (*) Maternal Exposure to Diethylstilbestrol during Pregnancy and Increased Breast Cancer Risk in Daughters (2014), by Leena Hilakivi-Clarke, published in the journal Breast Cancer Research (full-text)
- (*) Endocrine Disruption of the Epigenome: A Breast Cancer Link (2014), by Kevin C. Knower, et al., published in the journal Endocrine-Related Cancer (full-text)
- (*) Exposure to Diethylstilbestrol during Sensitive Life Stages: A Legacy of Heritable Health Effects (2013), by Casey E. Reed & Suzanne E. Fenton, et al., published in the journal Birth Defects Research: Part C (abstract only)
- (*) Exposures to Synthetic Estrogens at Different Times During the Life, and Their Effect on Breast Cancer Risk (2013), by Leena Hilakivie-Clarke, et. al, published in the Journal of Mammary Gland Biology and Neoplasia (abstract only)
- (*) Does Cancer Start in the Womb? Altered Mammary Gland Development and Predisposition to Breast Cancer due to in utero Exposure to Endocrine Disruptors (2013), by Ana M. Soto, et al., published in the Journal of Mammary Gland Biology and Neoplasia
- (*) Breast Cancer Following Diethylstilbestrol Exposure in Utero: Insights from a Tragedy (2012), by Hans-Olov Adami, et. al, published in the European Journal of Epidemiology (abstract only)
- (*) Prenatal Diethylstilbestrol Exposure and Breast Cancer (2012), by S. Frigo et al., published in the journal Gynécologie Obstétrique & Fertilité (abstract only)
- (*) Prenatal Exposure to Diethylstilbestrol and Long-term Impact on Breast and Reproductive Tract in Humans and Mice (2012), by R.R. Newbold, published in the Journal of Developmental Origins of Health and Disease (abstract only)
- (*) Mammography Screening Behaviors of Women Exposed Prenatally to Diethylstilbestrol (2012), by Elizabeth A. Camp, et. al, published in the Journal of Women’s Health (abstract only)
- (*) Comment: Breast Cancer Following Diethylstilbestrol Exposure in utero: A Tragedy? (2012), by Avrum Z. Bluming, published in the European Journal of Epiemiology
- (*) Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses (2012), by Laura N. Vandnberg, et al., published in the journal Endocrine Reviews (full-text)
- (*) Adverse Health Outcomes in Women Exposed in utero t 0 Diethylstilbestrol (2011), by Robert N. Hoover, et. al, published in the New England Journal of Medicine (full-text)
- (*) In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer (2010), by Leo F. Doherty, et al., published in the journal Hormones and Cancer (full-text)
- (*) Cancer Risk in DES Daughters (2010), by Janneke Verloop, et. al, published in the journal Cancer Causes & Control (full-text)
2000-2009 - (*) Breast Cancer Screening in Women Exposed in utero to Diethylstilbestrol (2009), by Elizabeth A. Camp, et. al, published in the Journal of Women’s Health (full-text)
- (*) Intrauterine Environments and Breast Cancer Risk: Meta-analysis and Systematic Review (2007), by Sue Kyung Park, et. al, published in the journal Breast Cancer Research
- (*) Cancer Risk in Women Prenatally Exposed to Diethylstilbestrol (2007), by Rebecca Troisi, et. al, published in the International Journal of Cancer (full-text)
- (*) Pregnancy and the Risk of Breast Cancer (2007), by Kara Britt, et al., published in the journal Endocrine-Related Cancer (abstract)
- (*) Early Life Events and Conditions and Breast Cancer Risk: From Epidemiology to Etiology (2007), by Dimitrios Trichopoulos, et al., published in the International Journal of Cancer (abstract)
- (*) Intrauterine Factors and Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Current Evidence (2007), by Dr. Fei Xue & Prof Karin B. Michels, published in The Lancet: Oncology
- (*) Diethylstilbestrol Increases Risk of Breast Cancer Death (2006), by Roger Dobson, published in BMJ (British Medical Journal) (news source)
- (*) Prenatal Diethylstilbestrol Exposure and Risk of Breast Cancer (2006), by Julie R. Palmer, et. al, published in the journal Cancer Epidemiology Biomarkers & Prevention (f-t)
- (*) Menstrual and Reproductive Characteristics of Women Whose Mothers were Exposed in utero to Diethylstilbestrol (DES) (2006), by Linda Titus-Ernstoff, et al., published in the International Journal of Epidemiology (full-text)
- (*) Intrauterine Exposures, Pregnancy Estrogens and Breast Cancer Risk: Where do we Currently Stand? (2006), by Pagona Lagiou, published in the journal Breast Cancer Research (full-text)
- (*) Management of Breast Cancer in Patients Prenatally Exposed to Diethylstilbestrol: Are we Prepared? (2005), by MS Mano, et. al, published in the journal The Breast (abstract)
- (*) Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature (2004), by Michelle D. Althuis, et al., published in the journal Cancer Epidemiology, Biomarkers & Prevention (full-text)
- (*) Risk of Breast Cancer in Women Exposed to Diethylstilbestrol in utero: Preliminary Results (United States) (2002), by Julie R. Palmer, et. al, published in the journal Cancer Causes & Control (abstract only)
- (*) Long-term Cancer Risk in Women Given Diethylstilbestrol (DES) during Pregnancy (2001), by L. Titus-Ernstoff, et. al, published in the British Journal of Cancer (abstract only)
1978-2000 - (*) DES Research Heats Up Again After Breast Cancer Finding (1999), by Mike Miller, published in the Journal of the National Cancer Institute (full-text)
- (*) Cancer Risk in Women Exposed to Diethylstilbestrol in Utero (1998), by Elizabeth E. Hatch, et. al, published in the Journal of the American Medical Association (JAMA) (abstract only)
- (*) Maternal Factors and Breast Cancer Risk Among Young Women (1998), by M. Sanderson, et al., published in the journal Paediatric and Perinatal Epidemiology (abstract only)
- (*) Prenatal and Perinatal Risk Factors for Breast Cancer in Young Women (1997), by H. A. Weiss, et al., published in the journal Epidemiology (abstract only)
- (*) Diethylstilbestrol and Risk of Fatal Breast Cancer in a Prospective Cohort of U.S. Women (1996), by Eugenia E. Calle, et. al, published in the American Journal of Epidemiology (full)
- (*) Diethylstilbestrol (DES) and Breast Cancer (1993), by KE Malone, published in the journal Epidemiological Review (abstract only)
- (*) Breast Cancer in Mothers Prescribed Diethylstilbestrol in Pregnancy: Further Follow-up (1993), by Theodore Colton, et. al, published in the Journal of the American Medical Association (JAMA) (abstract only)
- (*) Breast Cancer Epidemiology (1988), by J. L. Kelsey & G. S. Berkowitz, published in the journal Cancer Research (abstract only)
- (*) Breast Cancer in Mothers Given Diethylstilbestrol in Pregnancy (1984), by E. R. Greenberg, et. al, published in the New England Journal of Medicine (abstract only)
- (*) Cancer Risk Among Women Exposed to Exogenous Estrogens during Pregnancy (1984), by O.C. Hadjimichael, et al., published in JNCI: Journal of the National Cancer Institute (abstract only)
- (*) Diethylstilbestrol and the Risk of Cancer (1979), by L C Clark & K M Portier, published in the New England Journal of Medicine (abstract only)
- (*) A Twenty-Five-Year Follow-up Study of Women Exposed to Diethylstilbestrol during Pregnancy (1978), by Marluce Bibbo, et al, published in the New England Journal of Medicine (abstract only)
- (*) A Clinical Study of Lactation Suppression (1973), by Daniel J. Schwarz, et al., published in the journal Obstetrics & Gynecology